4//SEC Filing
Belloff Neil S. 4
Accession 0001415889-21-002682
CIK 0001035354other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:10 PM ET
Size
9.2 KB
Accession
0001415889-21-002682
Insider Transaction Report
Form 4
Belloff Neil S.
General Counsel and Secretary
Transactions
- Exercise/Conversion
Common Stock
2021-05-25+6,250→ 33,430 total - Tax Payment
Common Stock
2021-05-25$1.39/sh−1,835$2,551→ 31,595 total - Exercise/Conversion
Restricted Stock Units
2021-05-25−6,250→ 68,750 total→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F4]The remaining restricted stock units will vest ratably each quarter through February 25, 2024, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001741670
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:10 PM ET
- Size
- 9.2 KB